# Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer

> **NCT02494635** · — · TERMINATED · sponsor: **University of Southern California** · enrollment: 4 (actual)

## Conditions studied

- Bladder Papillary Urothelial Carcinoma
- Stage 0a Bladder Urothelial Carcinoma
- Stage 0is Bladder Urothelial Carcinoma
- Stage I Bladder Cancer With Carcinoma In Situ
- Stage I Bladder Urothelial Carcinoma
- Stage II Bladder Urothelial Carcinoma
- Stage III Bladder Urothelial Carcinoma
- Stage IV Bladder Urothelial Carcinoma

## Interventions

- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT02494635
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09-16
- **Primary completion:** 2019-02-22
- **Final completion:** 2019-02-22
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** The PI left institution
- **Last updated:** 2019-07-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02494635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02494635, "Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02494635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*